PillRx only · Injection · Intravenous
Arsenic Trioxide
Arsenic Trioxide
4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US8 NDCs
4 active makers
4 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
548
Rx · 2026 Q1
7.3K
Units dispensed
-10%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it4 active · 1 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | unknown | 2 | SUPPLYING |
| Sagent Pharmaceuticals | unknown | 2 | SUPPLYING |
| Gland Pharma Limited | unknown | 2 | SUPPLYING |
| Nexus Pharmaceuticals LLC | unknown | 1 | SUPPLYING |
| Ingenus Pharmaceuticals, LLC | unknown | 1 | EXITED 2028 |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Feb 24, 2026RESOLVEDShortage resolved: Arsenic Trioxide Injection (Ingenus Pharmaceuticals LLC)
Arsenic Trioxide Injection — reported in shortage by Ingenus Pharmaceuticals LLC. Therapeutic category: Oncology.
- Feb 24, 2026SHORTAGEDrug shortage: Arsenic Trioxide Injection (Ingenus Pharmaceuticals LLC)
Arsenic Trioxide Injection — reported in shortage by Ingenus Pharmaceuticals LLC. Therapeutic category: Oncology.